Share. Connect. Create. Grow. · Socialiya
Amgen drops ph. 1 obesity drug, upping pressure on MariTide

Amgen has ended development of its early-stage obesity drug AMG 513, foisting its hopes for a slice...

BUSINESS NEWS August 04, 2026

Amgen drops ph. 1 obesity drug, upping pressure on MariTide

Amgen has ended development of its early-stage obesity drug AMG 513, foisting its hopes for a slice of the massive weight loss market onto the shoulders of...

6 views 0 likes 0 comments
Share:
Amgen has ended development of its early-stage obesity drug AMG 513, foisting its hopes for a slice of the massive weight loss market onto the shoulders of...

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya